Literature DB >> 172587

Relationship of infectious murine leukemia virus and virus-related antigens in genetic crosses between AKR and the Fv-1 compatible strain C57L.

H Ikeda, W P Rowe, E A Boyse, E Stockert, H Sato, S Jacobs.   

Abstract

In a further genetic study of murine leukemia virus (MuLV) and its components we examined the backcross C57L X (C57L X AKR). This population was selected because strains AKR and C57L are both Fv-1n, and the restriction which the Fu-1b allele imposes on the output of virus was thereby obviated. The segregants were scored for three characters: (a) infectious Gross-AKR-type MuLV (V), in the tail; (b) group-specific antigen indicative of p30 internal viral protein, in spleen; and (c) GIX antigen, now thought to be indicative of gp69/71 viral envelope glycoprotein, on thymocytes. Our conclusions are: (a) It is confirmed that the AKR mouse has two unlinked chromosomal genes, Akv-1 and Akv-2, each of which can independently give rise to the life-long high output of MuLV that is characteristic of AKR mice. (b) Of the eight phenotypes that could possibly be derived from segregation of the three pairs of independent alternative traits, seven were observed, but on progeny testing only three were shown to reflect stably heritable genotypes; these were V+p30+GIX+ and V-p30-GIX- (the parental types) and V-p30+GIX+. A third, newly identified AKR gene, designated Akvp, segregating independently of Akv-1 and Akv-2, also determines expression of p30 and GIX but in this case independently of XC-detectable MuLV. (c) The four remaining observed phenotypes, which did not breed true on progeny testing, involved mostly antigen-negative parents yielding antigen-positive progeny; it is likely that these discrepancies represented suppression of phenotype by a maternal resistance factor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 172587      PMCID: PMC2190095          DOI: 10.1084/jem.143.1.32

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

1.  Maternal influence in experimental leukemia of mice.

Authors:  L W LAW
Journal:  Ann N Y Acad Sci       Date:  1954-01-15       Impact factor: 5.691

2.  Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses.

Authors:  J W Hartley; W P Rowe
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

3.  Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. V. Identification of a new murine viral protein, p15(E).

Authors:  H Ikeda; W Hardy; E Tress; E Fleissner
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

4.  Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30.

Authors:  H Ikeda; T Pincus; T Yoshiki; M Strand; J T August; E A Boyse; R C Mellors
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

5.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

6.  A distinct class of inducible murine type-C viruses that replicates in the rabbit SIRC cell line.

Authors:  R E Benveniste; M M Lieber; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

7.  Recovery of murine xenotropic type-C virus from C57L mice.

Authors:  P Arnstein; J A Levy; L S Oshiro; P J Price; W Suk; E H Lennette
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

8.  Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis.

Authors:  F Lilly; M L Duran-Reynals; W P Rowe
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

9.  Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus.

Authors:  J S Tung; E S Vitetta; E Fleissner; E A Boyse
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

10.  New mutant and congenic mouse stocks expressing the murine leukemia virus-associated thymocyte surface antigen GIX.

Authors:  E Stockert; E A Boyse; Y Obata; H Ikeda; N H Sarkar; H A Hoffman
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more
  8 in total

1.  Identification of ecotropic proviral sequences in high- and low-ecotropic-virus-producing mouse strains.

Authors:  J L Moore; H W Chan
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

2.  Murine resistance to street rabies virus: genetic analysis by testing second-backcross progeny and verification of allelic resistance genes in SJL/J and CBA/J mice.

Authors:  D L Lodmell; B Chesebro
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

3.  C-type virus protein p30 in blood from inbred mice correlates with their later incidence of leukemia.

Authors:  B A Nexø; H H Krog
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

4.  Emv-13 (Akv-3): a noninducible endogenous ecotropic provirus of AKR/J mice.

Authors:  H G Bedigian; N G Copeland; N A Jenkins; K Salvatore; S Rodick
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

5.  Heredity of the GIX thymocyte antigen associated with murine leukemia virus: segregation data simulating genetic linkage.

Authors:  E Stockert; E A Boyse; H Sato; K Itakura
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

6.  Expression of xenotropic murine leukemia viruses as cell-surface gp70 in genetic crosses between strains DBA/2 and C57BL/6.

Authors:  H C Morse; T M Chused; J W Hartley; B J Mathieson; S O Sharrow; B A Taylor
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

7.  Genetic mapping of the ecotropic virus-inducing locus Akv-2 of the AKR mouse.

Authors:  C A Kozak; W P Rowe
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

8.  Influence of Fv-1 alleles on cellular expression of gp70.

Authors:  J S Tung; E A Boyse; F W Shen
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.